AstraZeneca is paying $2.4bn for Fusion Pharmaceuticals - but actually is it getting AstraZeneca PLC (LSE:AZN) is acquiring Canadas Fusion Pharmaceuticals for $2.4 billion, in a bid to effectively keep up with Joneses…
AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase The deal is AstraZenecas second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to…
AstraZeneca to Buy Fusion Pharma for Up to $2.4 Billion AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as it seeks to transform cancer…
AstraZeneca to buy Fusion Pharma for $2 billion in cash By Reuters AstraZeneca to buy Fusion Pharma for $2 billion in cash…